Skip to content
Tuesday, April 21, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • A son of Holocaust survivors and the granddaughter of a Nazi confront their separate inheritances April 21, 2026
  • Israeli Culture Club flyers ended up in a urinal. Now the school board president is facing calls to resign. April 21, 2026
  • Rachel Goldberg-Polin doesn’t know if you can handle her pain April 21, 2026
  • At soldiers’ graves, the rows keep growing: Israel’s Memorial Day is shaped by new loss April 20, 2026
  • Michigan Democrats nominate Eli Savit, progressive Jewish prosecutor, for state attorney general April 20, 2026
  • Rahm Emanuel joins calls for end to US ‘financial aid’ to Israel April 20, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.